Trial Profile
A study evaluating non inferiority of nitazoxanide to metronidazole for the Treatment of Clostridium difficile Colitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Feb 2018
Price :
$35
*
At a glance
- Drugs Nitazoxanide (Primary) ; Metronidazole
- Indications Clostridium difficile infections; Colitis
- Focus Therapeutic Use
- 06 Feb 2017 New trial record.